Becton, Dickinson and Co. | BDX - Interest Expense On Debt


Becton, Dickinson and Co. reported $130M in Interest Expense on Debt for its fiscal quarter ending in September of 2026.





Interest Expense On Debt Change Date
Abbott USD 297M 2M Sep/2026
Agilent USD 29M 4M Jun/2026
Align Technology USD 9.96M 3.02M Jun/2026
AngioDynamics USD 102K 2K Sep/2025
Baxter International USD 64M 14M Jun/2026
Becton, Dickinson and Co. USD 130M 2M Sep/2026
Bio-Rad Laboratories USD 12.1M 200K Jun/2026
Boston Scientific USD 100M 4M Sep/2026
Cooper Companies USD 21.5M 600K Jun/2026
Danaher USD 135M 28M Sep/2026
Dentsply International USD 27M 5M Sep/2026
Dexcom USD 3.1M 100K Sep/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Globus Medical USD 5.53B 39.93M Sep/2026
Insulet USD 12.3M 1.3M Sep/2026
Integra LifeSciences USD 22.96M 33K Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 186M 10M Jun/2026
Solventum Corp USD 14.16B 78M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Tandem Diabetes Care USD 1.16B 5.29M Sep/2026
Teleflex USD 21.21M 6.75M Sep/2026
Terumo JPY 3.05B 1.58B Sep/2026
Thermo Fisher Scientific USD 417M 63M Sep/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026